课题基金 / 基金详情

New strategy based on the organogenesis signal control for periodontal disease

New strategy based on the organogenesis signal control for periodontal disease
基于器官发生信号控制的牙周病新策略
批准号:
21390553
负责人:
IZUMI Yuichi
金额:
$11.56万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

IZUMI Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
与健康对照组织相比,慢性牙周炎组织中Wnt5a mRNA表达上调。P. gingivalis LPS诱导THP-1单核细胞Wnt5a mRNA表达,在刺激后4小时达到峰值。P. gingivalis LPS诱导Wnt5a mRNA的上调高于大肠杆菌LPS。LPS受体TLR2和TLR4在THP-1细胞表面均有表达。P. gingivalis LPS诱导IkBa降解,并能提高NF-kB与DNA的结合活性。NF-kB抑制剂可抑制牙龈假单胞菌lps诱导的Wnt5a表达,提示NF-kB参与其中。此外,IFN-g协同增强了P. gingivalis lps诱导的Wnt5a的产生。药理研究和siRNA实验表明,STAT1在牙龈卟噬菌lps诱导的Wnt5a表达中起重要作用。这些结果表明,牙龈假单胞菌对Wnt5a表达的调节可能在牙周炎症过程中发挥重要作用,并为开发新的治疗方法提供了靶点。
英文摘要
Wnt5a mRNA expression was up-regulated in chronic periodontitis tissue as compared to healthy control tissue. P. gingivalis LPS induced Wnt5a mRNA in the human monocytic cell line THP-1 with a peak at 4 hrs after stimulation. P. gingivalis LPS induced higher up-regulation of Wnt5a mRNA than E. coli LPS. The LPS receptors TLR2 and TLR4 were equally expressed on the surface of THP-1 cells. P. gingivalis LPS induced IkBa degradation and was able to increase the NF-kB binding activity to DNA. P. gingivalis LPS-induced Wnt5a expression was inhibited by NF-kB inhibitors, suggesting NF-kB involvement. Furthermore, IFN-g synergistically enhanced the P. gingivalis LPS-induced production of Wnt5a. Pharmacological investigation and siRNA experiments showed that STAT1 was important for P. gingivalis LPS-induced Wnt5a expression. These results suggest that the modulation of Wnt5a expression by P. gingivalis may play an important role in the periodontal inflammatory process and serve a target for the development of new therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functions of PI3K and MAPK on Wnt5a expression in THP-1
PI3K和MAPK对THP-1中Wnt5a表达的作用
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Nanbara H, Kobayashi H, Izumi Y, et al]
通讯作者: et al
Analysis of microbiota associated with peri-implantitis using 16S rRNA gene clone library.
使用16S rRNA基因克隆文库分析与种植植物炎相关的微生物群。
DOI: 10.3402/jom.v2i0.5104
发表时间: 2010-05-24
期刊: Journal of oral microbiology
影响因子: 4.5
作者: [Koyanagi T, Sakamoto M, Takeuchi Y, Ohkuma M, Izumi Y]
通讯作者: Izumi Y
DOI: 10.1007/s10103-010-0761-5
发表时间: 2010-07-01
期刊: LASERS IN MEDICAL SCIENCE
影响因子: 2.1
作者: [Aleksic, Verica, Aoki, Akira, Izumi, Yuichi]
通讯作者: Izumi, Yuichi
DOI: --
发表时间: 2010
期刊: J Periodont Res
影响因子: --
作者: [Ohnishi H, Izumi Y.]
通讯作者: Izumi Y.
共 20 条
    The autoantibody effects of periodontopathic bacteria on threatened preterm labor and preterm birth.
    • 批准号:
      24659921
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      IZUMI Yuichi
    • 依托单位:
    Elucidation and reguration of the periodontal disease progression mechanism based on new inflammation adjustments(ANA and HMGB-1)
    New Concept of Antigen Presentation by Gingival Epithelial Cells in Periodontal Disease.
    • 批准号:
      14370712
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.64万
    • 财政年份:
      2002
    • 负责人:
      IZUMI Yuichi
    • 依托单位:
    New Strategy for Periodontal Treatment Based on Control of Angiogenesis in Periodontal Tissues using VEGF and Anti-VEGF.
    • 批准号:
      13557191
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2001
    • 负责人:
      IZUMI Yuichi
    • 依托单位:
    国内基金
    海外基金
    靶向Sox9/Wnt5a/NFAT信号轴促进睑板腺再生以治疗终末期睑板腺功能障碍的策略与机制研究
    • 批准号:
      2025JJ90130
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郭俞利
    • 依托单位:
    WNT5A突变(c.583G>A, p.E195K)通过激活非经典WNT信号/钙通路诱导手指发育畸形的机制研究
    • 批准号:
      2025JJ50475
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      曾磊
    • 依托单位:
    Wnt5a/Calpain6/Rac1通路激活毛囊黑素干细胞逆转毛发白化的机制研究
    外泌体递送活性Wnt5a促线粒体自噬改善帕金森病炎症环境的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李勇昂
    • 依托单位: